Sign in
4

Changes in Ownership

Vanda Pharmaceuticals Inc. Filed Acc 0001209191-19-015749

SVP & Chief Commercial Officer sold 881 shares at an average $20.04 ($17,655)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Reverberi Gian Piero SVP & Chief Commercial Officer 2019-03-01 Sale −438 $20.17 $8,832 168,432 D
Reverberi Gian Piero SVP & Chief Commercial Officer 2019-03-04 Sale −443 $19.92 $8,823 167,989 D
Open-market sales · 881 sh · avg $20.04 · $17,655
Loading xslF345X03/doc4.xml…